Clinical Trial Update: Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial assessed the combination of ascorbic acid with chemotherapy for locally advanced, unresectable, or recurrent pancreatic cancer; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Ascorbic acid (Vitamin C)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2020-01-18